The Role of GLP1 Receptor Agonists and Multi-agonist Incretin Therapies for Specific Obesity-related Health Conditions: Evidence and Rationale for Prioritisation
Albor C., Anyiam O., Boyle LD., Makaronidis J., Tan R., Iftikhar S., Burzic A., Lajeunesse Trempe F., Stanley M., Bhatti A., Scragg J., Badawy L., Moqeem K., Idris I., Andrews RC., Sen Gupta P., Hughes D., McCullough K., Tan T., McGowan B.